MedTrace Logo

Characterization of Arrhythmia-induced Cardiomyopathy

NCT05662293 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2700

Last updated 2025-03-04

No results posted yet for this study

Summary

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.

Conditions

Interventions

OTHER

Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)

Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part). The assessment will be done via mail, letter or phone

OTHER

Data collection: Quality of Life (QoL) Questionnaire (prospective part)

Data collection: Quality of Life (QoL) Questionnaire (prospective part). The questionnaire "EQ-5D-5L questionnaire" will be used to assess quality of life.

OTHER

Data collection (retrospective study)

Anonymized search and review of patients electronic health records of the University Hospital of Basel for patients with a reduced LVEF and a concomitant (±1year or after any observation of a reduced LVEF in imaging) diagnosis of arrhythmia known to be causing AiCM.

OTHER

Data collection (prospective study database)

Data collection on alcohol consumption, family history, rhythm disorder, hospitalizations, cardiac assessments, adverse events at baseline, 6 months, 1 year, 2 years and 5 years.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Patrick Badertscher, MD · University Hospital Basel, Department of Cardiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2026-01-31
Completion
2027-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05662293 on ClinicalTrials.gov